RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 793 filers reported holding RAYTHEON CO in Q1 2014. The put-call ratio across all filers is 1.22 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $271,000 | -0.4% | 1,234 | -10.8% | 0.05% | -11.9% |
Q3 2019 | $272,000 | +3.8% | 1,384 | -8.3% | 0.06% | 0.0% |
Q2 2019 | $262,000 | -8.4% | 1,509 | -3.8% | 0.06% | -11.9% |
Q1 2019 | $286,000 | +13.9% | 1,569 | -4.1% | 0.07% | +3.1% |
Q4 2018 | $251,000 | -30.1% | 1,636 | -5.8% | 0.06% | -19.8% |
Q3 2018 | $359,000 | +7.2% | 1,736 | 0.0% | 0.08% | -2.4% |
Q2 2018 | $335,000 | -13.2% | 1,736 | -3.0% | 0.08% | -13.5% |
Q1 2018 | $386,000 | +8.7% | 1,790 | -5.4% | 0.10% | +5.5% |
Q4 2017 | $355,000 | +0.6% | 1,892 | 0.0% | 0.09% | -4.2% |
Q3 2017 | $353,000 | +7.0% | 1,892 | -7.3% | 0.10% | 0.0% |
Q2 2017 | $330,000 | 0.0% | 2,042 | -5.8% | 0.10% | -2.1% |
Q1 2017 | $330,000 | +9.6% | 2,167 | +2.4% | 0.10% | +2.1% |
Q4 2016 | $301,000 | +1.0% | 2,117 | -3.4% | 0.10% | -2.1% |
Q3 2016 | $298,000 | -1.7% | 2,192 | -1.7% | 0.10% | -12.6% |
Q2 2016 | $303,000 | +20.7% | 2,230 | +9.0% | 0.11% | +20.7% |
Q1 2016 | $251,000 | -1.6% | 2,046 | 0.0% | 0.09% | +2.2% |
Q4 2015 | $255,000 | +12.8% | 2,046 | -1.2% | 0.09% | +7.1% |
Q3 2015 | $226,000 | -14.4% | 2,071 | -14.5% | 0.08% | -8.7% |
Q1 2015 | $264,000 | -12.6% | 2,421 | -13.4% | 0.09% | -15.6% |
Q4 2014 | $302,000 | +4.5% | 2,796 | -1.8% | 0.11% | -0.9% |
Q3 2014 | $289,000 | +12.9% | 2,846 | +2.7% | 0.11% | +18.3% |
Q2 2014 | $256,000 | -6.6% | 2,771 | 0.0% | 0.09% | -12.3% |
Q1 2014 | $274,000 | +15.6% | 2,771 | +5.9% | 0.11% | +12.8% |
Q4 2013 | $237,000 | – | 2,617 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |